Menu
GeneBe

rs11803533

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001100.4(ACTA1):c.130-5T>C variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.192 in 1,613,794 control chromosomes in the GnomAD database, including 33,901 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 6596 hom., cov: 32)
Exomes 𝑓: 0.19 ( 27305 hom. )

Consequence

ACTA1
NM_001100.4 splice_region, splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.00004295
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.545
Variant links:
Genes affected
ACTA1 (HGNC:129): (actin alpha 1, skeletal muscle) The product encoded by this gene belongs to the actin family of proteins, which are highly conserved proteins that play a role in cell motility, structure and integrity. Alpha, beta and gamma actin isoforms have been identified, with alpha actins being a major constituent of the contractile apparatus, while beta and gamma actins are involved in the regulation of cell motility. This actin is an alpha actin that is found in skeletal muscle. Mutations in this gene cause a variety of myopathies, including nemaline myopathy, congenital myopathy with excess of thin myofilaments, congenital myopathy with cores, and congenital myopathy with fiber-type disproportion, diseases that lead to muscle fiber defects with manifestations such as hypotonia. [provided by RefSeq, Sep 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 1-229432885-A-G is Benign according to our data. Variant chr1-229432885-A-G is described in ClinVar as [Benign]. Clinvar id is 93547.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-229432885-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.462 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ACTA1NM_001100.4 linkuse as main transcriptc.130-5T>C splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000366684.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ACTA1ENST00000366684.7 linkuse as main transcriptc.130-5T>C splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_001100.4 P1
ACTA1ENST00000366683.4 linkuse as main transcriptc.130-5T>C splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 5
ACTA1ENST00000684723.1 linkuse as main transcriptc.-6-5T>C splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant

Frequencies

GnomAD3 genomes
AF:
0.263
AC:
39900
AN:
151896
Hom.:
6571
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.468
Gnomad AMI
AF:
0.225
Gnomad AMR
AF:
0.261
Gnomad ASJ
AF:
0.331
Gnomad EAS
AF:
0.161
Gnomad SAS
AF:
0.168
Gnomad FIN
AF:
0.115
Gnomad MID
AF:
0.307
Gnomad NFE
AF:
0.172
Gnomad OTH
AF:
0.277
GnomAD3 exomes
AF:
0.208
AC:
52169
AN:
250470
Hom.:
6207
AF XY:
0.202
AC XY:
27325
AN XY:
135576
show subpopulations
Gnomad AFR exome
AF:
0.467
Gnomad AMR exome
AF:
0.264
Gnomad ASJ exome
AF:
0.330
Gnomad EAS exome
AF:
0.176
Gnomad SAS exome
AF:
0.180
Gnomad FIN exome
AF:
0.117
Gnomad NFE exome
AF:
0.175
Gnomad OTH exome
AF:
0.197
GnomAD4 exome
AF:
0.185
AC:
270509
AN:
1461778
Hom.:
27305
Cov.:
41
AF XY:
0.184
AC XY:
134003
AN XY:
727176
show subpopulations
Gnomad4 AFR exome
AF:
0.479
Gnomad4 AMR exome
AF:
0.270
Gnomad4 ASJ exome
AF:
0.325
Gnomad4 EAS exome
AF:
0.156
Gnomad4 SAS exome
AF:
0.179
Gnomad4 FIN exome
AF:
0.116
Gnomad4 NFE exome
AF:
0.173
Gnomad4 OTH exome
AF:
0.203
GnomAD4 genome
AF:
0.263
AC:
39976
AN:
152016
Hom.:
6596
Cov.:
32
AF XY:
0.259
AC XY:
19248
AN XY:
74354
show subpopulations
Gnomad4 AFR
AF:
0.468
Gnomad4 AMR
AF:
0.262
Gnomad4 ASJ
AF:
0.331
Gnomad4 EAS
AF:
0.160
Gnomad4 SAS
AF:
0.167
Gnomad4 FIN
AF:
0.115
Gnomad4 NFE
AF:
0.172
Gnomad4 OTH
AF:
0.277
Alfa
AF:
0.220
Hom.:
2542
Bravo
AF:
0.287
Asia WGS
AF:
0.198
AC:
687
AN:
3478
EpiCase
AF:
0.190
EpiControl
AF:
0.190

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJan 13, 2015c.130-5T>C in intron 2 of ACTA1: This variant is not expected to have clinical s ignificance because it has been identified in 45.0% (1983/4406) of African Ameri can chromosomes from a broad population by the NHLBI Exome Sequencing Project (h ttp://evs.gs.washington.edu/EVS; dbSNP rs11803533). -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoAug 15, 2013- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Aug 22, 2013- -
Actin accumulation myopathy Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Congenital myopathy with fiber type disproportion Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Familial restrictive cardiomyopathy Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
Cadd
Benign
2.4
Dann
Benign
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000043
dbscSNV1_RF
Benign
0.024
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs11803533; hg19: chr1-229568632; COSMIC: COSV64203448; API